Status:

COMPLETED

Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects

Lead Sponsor:

Certmedica International GmbH

Conditions:

Weight Loss

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The purpose of the study is to evaluate the effect on weight loss in a group of subjects suffering from overweight and mild obesity (BMI between 25 and 32 Kg/m2) and with weight \> 75 Kg/m2 being admi...

Detailed Description

The primary objective of the study is to evaluate the effect on weight loss in a group of subjects suffering from overweight and mild obesity (BMI between 25 and 32 Kg/m2) and with weight \> 75 Kg/m2 ...

Eligibility Criteria

Inclusion

  • Signed written informed consent
  • Age between 18-65
  • Both sexes - mandatory adequate contraceptive method for women in fertility age
  • BMI between 25-32 kg/m2 and weigh in \> 75 kg, with no previous diet-therapy attempts with at least a 5% weight loss in the last year
  • No 3 kg weight fluctuation in the last 3 months
  • Beck Depression Inventory (BDI) score \< 20
  • Binge Eating Scale (BES) score \< 27

Exclusion

  • Shellfish allergy or to any other ingredient in the product
  • Previous diet-therapy attempts with at least a 5% weight loss in the last year
  • 3 kg weight fluctuation in the last 3 months
  • Presumed or confirmed pregnancy
  • No contraceptive method for women in fertility age
  • Cardiopathies, nephropathies, hepatopathies, bronchopneumopathies, hemopathies dermopathies clinically significant chronic degenerative CNS (Central Nervous System) diseases
  • Active peptic ulcer, ulcerative colitis, Crohn disease, celiac disease, inflammatory bowel disease
  • Alcoholism
  • Epilepsy
  • Past or current malignancies
  • Intellectual disability
  • Significant motor disability
  • Drug abuse
  • Autoimmune diseases
  • Symptomatic cholelithiasis

Key Trial Info

Start Date :

April 24 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 20 2021

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04375696

Start Date

April 24 2020

End Date

December 20 2021

Last Update

November 22 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Azienda di Servizi alla Persona Istituzioni Assistenziali Riunite di Pavia

Pavia, Lombardy, Italy, 27100